英伟达
NVDA
超微电脑
SMCI
特斯拉
TSLA
4
Palantir
PLTR
5
Applovin
APP
美股市场个股详情
ARTV Artiva Biotherapeutics
- 3.860
- +0.100+2.66%
收盘价 02/26 16:00 (美东)
- 3.860
- 0.0000.00%
盘后 16:05 (美东)
9375.68万总市值-1.53市盈率TTM
3.980最高价3.680最低价3.83万股成交量3.730今开3.760昨收14.79万成交额0.89%换手率亏损市盈率(静)2428.93万总股本17.31052周最高0.47市净率1668.71万流通值3.37052周最低--股息TTM432.31万流通股17.310历史最高--股息率TTM7.98%振幅3.370历史最低3.861平均价1股每手
Artiva Biotherapeutics所有资讯
Artiva Biotherapeutics | 4：持股变动声明-董事 Baker Daniel G.
Artiva Biotherapeutics | 3：首次持股声明-董事 Baker Daniel G.
Artiva Biotherapeutics | SC 13G/A：超过5%持股股东披露文件(修正)-venBio Global Strategic Fund III, L.P.(6.3%),venBio Global Strategic GP III, L.P.(6.3%)等
Artiva Biotherapeutics | 4：持股变动声明-董事 MOORE ALISON
Artiva Biotherapeutics | 3：首次持股声明-董事 MOORE ALISON
Artiva Biotherapeutics | 4：持股变动声明-高管 Raymon Heather
Artiva Biotherapeutics | 4：持股变动声明-高管 Graef Thorsten
Artiva Biotherapeutics | 4：持股变动声明-高管 Horan Christopher
Artiva Biotherapeutics | 4：持股变动声明-高管 Bush Jennifer
Artiva Biotherapeutics | 4：持股变动声明-高管 Krishnamohan Neha
Artiva Biotherapeutics | SC 13D/A：超过5%持股股东披露文件(修正)-RA Capital Management, L.P.(40.6%),Peter Kolchinsky(40.6%)等
Artiva Biotherapeutics | SC 13G：超过5%持股股东披露文件-venBio Global Strategic Fund III, L.P.(7.8%),venBio Global Strategic GP III, L.P.(7.8%)等
Artiva Biotherapeutics | SC 13G：超过5%持股股东披露文件-Andrew J. Schwab(10.1%),Kush Parmar(10.1%)等
Artiva Biotherapeutics | SC 13G：超过5%持股股东披露文件-Venrock Healthcare Capital Partners III, L.P.(6.9%),VHCP Co-Investment Holdings III, LLC(6.9%)等
Artiva Biotherapeutics | SC 13D：超过5%持股股东披露文件-RA Capital Management, L.P.(42.3%),Peter Kolchinsky(42.3%)等
Artiva Biotherapeutics | SC 13D：超过5%持股股东披露文件-GC Corp.(19.6%),Yong-Jun Huh(19.6%)等
Artiva Biotherapeutics | 4：持股变动声明-董事 RA CAPITAL MANAGEMENT, L.P.
Artiva Biotherapeutics | 4：持股变动声明-股东 5AM Partners VI, LLC
Artiva Biotherapeutics | 4：持股变动声明-股东 Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Artiva Biotherapeutics | 4：持股变动声明-股东 venBio Global Strategic Fund III, L.P.